🏢 官网IRTKNODoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 06:30:27(美东 10-21 18:30)·⟳ 抓取 06:32:13回填·⚡ 决策 10-22 06:33:24 +2m57s·5.8 天前
Teknova（TKNO）宣布将于2026年11月4日盘后发布Q3财报，稿件不含任何财务数字
本稿为财报发布日期的程序性 save-the-date 通知，全文无营收、利润、指引、订单等任何增量事实；且同一通稿的 GlobeNewswire 版本已在约2分钟前（10-21 22:32 UTC 抓取窗口）由 wire 源按「不做」处理，本条 IR 页版本无新增信息。另注意10月20日公司已发布Q3初步业绩并同步启动股权发售（已另行研判为不做），本日程稿不改变该判断。
📄 原文TKNO↗ 原文
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
October 21, 2026 at 6:30 PM EDT PDF Version HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“…
不做 Alpha Teknova, Inc.（TKNO.US）
纯财报发布日期与电话会日程预告（save-the-date），无营收/利润/指引/订单等任何增量事实，方向中性、无预期差与edge；同一通稿wire版本刚被处理为不做，等待2026-11-04盘后实际Q3财报的surprise再研判
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Teknova 仅通知11月4日盘后发财报并开电话会，不含任何数字或指引，属中性程序公告、无交易edge；待11月4日实际财报surprise再独立研判。
🔎 新鲜度:最早出现 2026-10-21 · 扩散 low · price-in 风险 low ↗
主要风险
- 11月4日盘后正式财报及在途股权发售条款才是实质变量，本日程稿不提供任何方向信息，不应据此提前建仓
先例如何影响了这次决策
对本次决策的影响:未改变结论；纯日程预告直接以NO_INCREMENTAL_FACT回避
方向:无需先例：事件本身无任何财务或经营增量，不产生方向性预期，先例无法改变结论
涨幅量级:不适用
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 2,195 ms
{"result": "search_processed_events:agent query=`alpha teknova tkno third quarter earnings announcement schedule | teknova q3 2026 financial results date november 4 webcast`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 72.0/72 小时、27515 条本臂决策(完整)，返回 10 条候选。\n• 10-21 22:32 UTC(北京 10-22 06:32) [bm25:68%] 不做 TKNO.US (wire)
原文全文
展开原文 · 2,211 字
October 21, 2026 at 6:30 PM EDT
PDF Version
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2026, on Wednesday, November 4, 2026, following the close of market.
Teknova will host a webcast and conference call on Wednesday, November 4, 2026, beginning at 6:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the
Investor Relations
section of the Teknova website or by using this
link
. If you would like to participate in the call, please register for the webcast
here
to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in genomics, molecular diagnostics, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture and cryopreservation media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
PDF Version
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2026, on Wednesday, November 4, 2026, following the close of market.
Teknova will host a webcast and conference call on Wednesday, November 4, 2026, beginning at 6:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the
Investor Relations
section of the Teknova website or by using this
link
. If you would like to participate in the call, please register for the webcast
here
to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in genomics, molecular diagnostics, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture and cryopreservation media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
0bf7340224· 2026-10-22 06:33 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前